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Background:Monitoring of intracranial pressure (ICP) is a critical component in the management
of intracranial hypertension. Safety, efficacy, and optimal location of microsensor devices have
not been defined in dogs.
Hypothesis/Objective: Assessment of ICP using a microsensor transducer is feasible in anesthe-
tized and conscious animals and is independent of transducer location. Intraparenchymal trans-
ducer placement is associated with more adverse effects.
Animals: Seven adult, bred-for-research dogs.
Methods: In a prospective investigational study, microsensor ICP transducers were inserted into
subdural and intraparenchymal locations at defined rostral or caudal locations within the rostro-
tentorial compartment under general anesthesia. Mean arterial pressure and ICP were measured
continuously during physiological maneuvers, and for 20 hours after anesthesia.
Results: Baseline mean  SD values for ICP and cerebral perfusion pressure were 7.2  2.3 and
78.9  7.6 mm Hg, respectively. Catheter position did not have a significant effect on ICP mea-
surements. There was significant variation from baseline ICP accompanying physiological
maneuvers (P < .001) and with normal activities, especially with changes in head position
(P < .001). Pathological sequelae were more evident after intraparenchymal versus subdural
placement.
Conclusions and Clinical Importance: Use of a microsensor ICP transducer was technically
straightforward and provided ICP measurements within previously reported reference ranges.
Results support the use of an accessible dorsal location and subdural positioning. Transient fluc-
tuations in ICP are normal events in conscious dogs and large variations associated with head
position should be accounted for when evaluating animals with intracranial hypertension.
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1 | INTRODUCTION
Intracranial pressure (ICP) refers to the pressure exerted by the
intracranial contents against an inelastic cranial vault and is a
common consideration in patients with increased intracranial vol-
ume secondary to brain trauma, organic brain disease, or after
intracranial surgery. Continuous measurement of prolonged intra-
cranial hypertension (ICH) generally is recommended as standard of
care in human medicine, particularly in cases of severe head
trauma.1–3 Monitoring ICP may provide timely information needed
to guide early therapeutic intervention, assess response to treat-
ment strategies, decrease indiscriminant treatments, and provide
data relevant to prognosis.1,3,4
Abbreviations: CPP, cerebral perfusion pressure; CSF, cerebrospinal fluid; CVP,
central venous pressure; ETCO2, end-tidal partial pressure of carbon dioxide;
HR, heart rate; ICH, intracranial hypertension; ICP, intracranial pressure; LS,
least square; MAP, mean arterial pressure; PaCO2, arterial carbon dioxide partial
pressure; PaO2, arterial oxygen partial pressure
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Cerebral blood flow is critical for normal brain function and is a
function of cerebral perfusion pressure (CPP), mean arterial pressure
(MAP), and cerebral vascular tone or resistance. Although defining ICP
is integral to monitoring CPP (CPP = MAP-ICP), measurement in vet-
erinary practice has been limited because of expense, technical skills
required for monitor placement, and compatibility of available moni-
toring systems with noncompliant animals. Intraventricular ICP
devices, fluid-coupled to an external transducer, are considered the
“gold standard” for measuring ICP in people,5 and similar approaches
have been reported from a study using experimental dogs.6–13 How-
ever, marked variation in skull landmarks, variation in ventricular size
and location, and the impracticalities of cerebellomedullary cistern
placement together with the requirement to maintain the external
transducer at head level limit the feasibility of ventricular placement
in most clinical situations.
Nonfluid coupled ICP transducers using either catheter tip minia-
ture strain gauges or fiber-optic-linked catheter tip diaphragm tech-
nology have distinct advantages over external transducers because
these devices do not require “leveling” with the head, although they
cannot be recalibrated to zero once they are inserted. Intracranial
fiber-optic or solid state capacitance systems have been shown to
provide accurate determination of ICP in both cats14,15 and
dogs,10,16–22 but substantial limitations of this system include the
necessity of anchoring the device to the skull by means of a subarach-
noid bolt and the inherent fragility of the fiber optics.
Intracranial strain-gauge pressure-sensing devices consisting of a
miniaturized silicon transducer enclosed in a titanium case and
implanted in the tip of a flexible nylon-covered cable have been
described for measurement of ICP in both awake and anesthetized
horses under a variety of conditions.23–29 Their flexibility, low profile
design and ease of use mean they are more easily operated, less prone
to breakage and better tolerated in the conscious animal. Data sup-
porting optimal placement of strain-gauge ICP monitoring devices in
dogs, in relation to consistency of readings and adverse effects, are
not available.
The purposes of our study were to: (1) examine the feasibility of
using a transducer-tip intracranial ICP monitor in dogs; (2) determine
the variation in ICP measurements obtained from various anatomical
locations (subdural versus intraparenchymal; rostral versus caudal)
within the cranial vault; (3) evaluate the effects of general anesthesia,
recovery, and behavior on ICP measurements in normal dogs; and
(4) evaluate histologically the acute effects of subdural versus intra-
parenchymal catheter placement on intracranial tissues.
2 | MATERIALS AND METHODS
This was a prospective investigational study conducted at the Univer-
sity of California, Davis, School of Veterinary Medicine.
2.1 | Animals
Seven neurologically normal bred-for-research, spayed female hounds,
ranging in age from 18 months to 8 years (mean, 5.2 years) were stud-
ied. Body weights varied from 27 to 35 kg (mean, 31 kg). For entry
into the study, each dog was required to be healthy based on normal
physical and neurological examinations and results of CBC, serum bio-
chemistry panel, and urinalysis. Animals were cared for according to
the principles outlined in the National Institutes of Health Guide for
the Care and Use of Laboratory Animals, and the study protocol was
approved by the Animal Care and Use Committee at the University of
California, Davis.
2.2 | Anesthesia
After being fasted for 8 hours, each dog was premedicated with atro-
pine (0.03 mg/kg SC), acepromazine (0.01 mg/kg), and butorphanol
(0.4 mg/kg). Anesthesia was induced with thiopental (10 mg/kg) and
maintained with isoflurane in oxygen. Animals were kept at a surgical
plane of anesthesia during transducer placement by administration of
isoflurane at 1.3-1.5 minimum alveolar concentration, and end-tidal
CO2 (ETCO2) was maintained between 30 and 35 mm Hg using posi-
tive pressure ventilation. Heart rate, body temperature, MAP, and
central venous pressure (CVP) were monitored continuously during
anesthesia and recovery. Arterial blood gases were measured every
30 minutes during anesthesia.
2.3 | Surgical procedure
After anesthetic induction, an 18-gauge 2.5-inch catheter was
inserted percutaneously into the right cephalic vein and a 20-gauge
70-cm drum catheter was inserted percutaneously into the right lat-
eral saphenous vein and advanced to the level of the 10th rib. A uri-
nary catheter was placed to monitor urine output during anesthesia
and recovery.
The head was shaved, aseptically prepared, and draped with ster-
ile surgical drapes. A standard dorsal midline surgical approach to the
cranium was performed exposing the frontal, parietal, and occipital
bones bilaterally. Masseter and temporalis muscles were retracted lat-
erally. Rostral and caudal burr-hole craniectomies were performed on
the left and right sides of the cranium using a high-speed pneumatic
drill (Surgairtome, Linvatec Inc., Key Largo, Florida). Rostral sites were
located 1 cm from the midline immediately caudal to the bregma, and
caudal sites were located 1 cm from the midline, and 2 cm caudal to
the rostral site. These sites resulted in transducer placements located
over the boundary of the postcruciate and suprasylvian gyri rostrally,
and ectomarginal gyrus caudally.30,31 Codman MicroSensor ICP trans-
ducers (Codman Microsensor, Codman & Shurtleff Inc., Raynham,
Massachusetts) were used, consisting of a miniature strain-gauge
pressure sensor mounted in a titanium case at the end of a 100-cm
flexible nylon covered cable (Figure 1). Functionality and accuracy of
the transducers were verified preplacement by measuring pressure
within a column of distilled water of known height. The absolute error
of transducer readings was ≤1 mm Hg and was within manufacturer
specifications. Before placement, transducers were electronically zer-
oed and calibrated in a shallow container of sterile saline (0.9% NaCl
solution) as specified by the manufacturer. All transducers were
inserted through 1 mm durotomy incisions. Intraparenchymal trans-
ducers were placed to a depth of 1.5 cm in the right rostral and caudal
sites. For subdural placement, two 90 bends were made in the
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transducer cable, 1 and 2 cm away from the strain gauge at the end of
the transducer cable so that the strain gauge rested on the pia mater
(Figure 1). Subdural transducers were placed in the left rostral and
caudal sites. Transducers were secured in place with bone wax in the
burr hole site and were connected to a cable that in turn connected to
the Codman MicroSensor interface control unit (Codman ICP Express,
Codman & Shurtleff Inc.). Occlusion of the jugular vein was used to
test for in vivo functionality of all transducers resulting in detection of
a consistent increase in ICP of at least 5-10 mm Hg within
15-30 seconds. The ICP catheters were sutured to the ventral aspect
of the temporalis muscle alongside the external sagittal crest to exit
the incision caudally, between sutures in the closure. The SC and sub-
cuticular tissues were closed using 3-0 polydioxanone in a simple con-
tinuous pattern, and skin staples were used to close the skin with the
ICP catheters exiting from the caudal aspect of the incision. Additional
fixation for the nylon tubing was provided using adhesive tape encir-
cling the catheters, affixed externally with skin staples between the
tape and the skin over the dorsum of the neck.
2.4 | Data collection
Intracranial pressure was recorded continuously from all 4 catheters
during anesthesia (4 hours), recovery, and after recovery for a total
time period of 24 hours. During anesthesia, dogs were positioned in
ventral recumbency. The MAP and CVP were measured by use of
fluid-filled catheters attached to strain-gauge transducers positioned
at the level of the heart and were calibrated against mercury and
water manometers, respectively. Data were recorded by use of a
multiple-channel chart recorder (Grass Model 7D, Statham Medical
Instruments, Hato Rey, Puerto Rico) or digital output display (Model
90603A, Spacelabs Medical, Redmond, Washington). The pH, PaCO2,
and PaO2 in blood samples, obtained every 30 minutes during
anesthesia from the dorsal pedal artery, were determined by use of an
automated blood gas analyzer (ABL 5, Radiometer America, Westlake,
Ohio). Values were corrected on the basis of body temperature as
measured by esophageal probe.
2.5 | ICP manipulations
Jugular occlusion was achieved by placing a blood pressure cuff cir-
cumferentially around the neck and slowly inflating the cuff to 90 mm
Hg. Intracranial pressure, MAP, CVP, heart rate (HR), and body tem-
perature were recorded at each 10 mm Hg increase in jugular occlu-
sion pressure until occlusion pressures reached 90 mm Hg.
End-tidal CO2 increase from 32 to 70 mm Hg was achieved by
removing the soda lime canister from the anesthetic machine. Intra-
cranial pressure, MAP, CVP, HR, and body temperature were recorded
at each 10 mm Hg increase in ETCO2.
During the recovery period, ICP, MAP, HR, and body temperature
were recorded every 15 minutes. After recovery from anesthesia, ICP
MAP, HR, and body temperature were recorded every 2 hours with
dogs in sternal recumbency and in a standing position. Additionally,
ICP measurements were recorded at least once in every 2 hours when
dogs assumed various body postures including standing with head up
and head down, and in sternal recumbency with head up and head
down. Head down position was achieved by offering food placed at
floor level, and elevation was achieved by holding food above the
dog’s head resulting in increase of the head level with an angle of the
nasal plane >45 from horizontal. Intracranial pressure measurements
also were recorded intermittently during ongoing normal activities
such as drinking, eating, walking, stretching, and playing (moving head
from side to side) during each 2-hour interval. Dogs were monitored
continuously by a board-certified neurologist during the 24-hour
recording period for any neurological deficits and for signs of
FIGURE 1 Schematic drawing illustrating the subdural and intraparenchymal placement of the Codman MicroSensor transducers. The nylon
cable is purposefully kinked at 90 so that the opening in the pressure sensor in the strain gauge at the tip of the catheter lies in close contact
with the surface of the brain. Bending and kinking the cable in this manner does not alter the function of the transducer. The cable interfaces
with the Codman Intracranial Pressure (ICP) Express to display ICP measurement. The MicroSensor transducer (inset) measures 1.0 mm by
3.0 mm and consists of a microchip pressure sensor enclosed in a titanium case. The flexible nylon cable connecting the transducer to a pressure
monitor measures 0.7 mm in diameter
710 STURGES ET AL.
discomfort or apparent pain, including vocalization, rubbing, or
scratching of the head or cable insertion sites and altered behavior
including change in body posture, change in demeanor, altered reac-
tion to touch, altered interaction with the investigator, altered mobil-
ity, and decreased appetite.
2.6 | Pathology
To verify transducer position and assess local effects of transducer
placement on the brain parenchyma, all dogs were euthanized using
pentobarbital/phenytoin (6 mg/kg IV; Beuthanazia-D, Merck Animal
Health, Madison, New Jersey) at the conclusion of the 24-hour
recording period and the brain was removed for pathological examina-
tion. The entire brain was examined for histopathological alterations
created by the transducer, either from initial placement or movement
of the transducer during normal activities in the recovering or awake
dog. Intracranial pressure transducer cables were cut close to the
point of insertion into the skull to preserve identification of the sub-
dural or intraparenchymal location of the transducer. Then, methylene
blue was used to mark transducer tracks in the ICP monitoring sites
once the brain was removed. Brains and skulls were immersion fixed
in 10% buffered formalin for a minimum of 7 days and brains were
sectioned into 3-mm thick sections including the marked catheter
insertion sites, and gross lesions were digitally photographed. Brain
tissue sections were processed for routine paraffin embedding and
5-μm thick sections were routinely stained with hematoxylin and
eosin.
2.7 | Statistical analysis
All data analyses were conducted using R (version 3.4.1, R Core Team,
2017. R Foundation for Statistical Computing, Vienna, Austria) with
the R package lme4.32 A series of linear mixed effects models was
generated with dog subjects as random effects, and with the
between-subject fixed effect of catheter placement and various physi-
ological manipulations of ICP during the 3 separate experiments (vari-
able jugular occlusion pressure, variable increases in ETCO2, and
variable position of head and body relative to the heart) as individual
test variables. Visual inspection of residual plots for each model did
not identify any large deviations from homoscedasticity or normality.
Likelihood ratio tests were used to assess the importance of fixed
effects. Pairwise comparisons of fixed effect levels were tested using
Tukey’s adjustment. Statistical significance was considered for
P values <.05.
3 | RESULTS
All catheters (28 total) were placed in all dogs without immediate sur-
gical complications. Post-anesthesia, all catheters were functional for
the 24-hour period of the study and were tolerated well by all dogs
with no subjective evidence of discomfort or apparent pain. No neu-
rological deficits were observed during the 24-hour period. Necropsy
of Dog 4 identified an intracranial meningioma and data from this dog
was excluded from the analysis. Anesthesia technical issues resulted
in ETCO2 manipulation data being unavailable for 1 dog. All dogs were
normocapnic and normoxemic without evidence of acid-base distur-
bances through the entire study, with the exception of data acquired
during manipulation of ETCO2 (Table 1).
3.1 | Effect of transducer location
Intracranial pressure measurements did not differ significantly across
transducer sites (rostral, caudal, intraparenchymal, and subdural) mea-
sured at baseline time points before or after physiological manipula-
tions (P = .19; Figure 2). Subsequent analysis of physiological
maneuvers was performed on pooled data from all 4 transducer sites.
Mean ICP and CPPs at baseline and maximal manipulation state are
summarized in Table 1.
3.2 | Effect of physiological maneuvers
Significant increases in ICP were seen with both increasing jugular
occlusion pressure (P < .001) and increasing ETCO2 (P < .001), and
the effect was true for each transducer placement. Pairwise compari-
sons showed significant differences in ICP with jugular occlusion pres-
sure differences across 20, 40, and 80 mm Hg (P < .05 for all). The
magnitude of effect on ICP was decreased at higher occlusion pres-
sures. (Figure 3, Table 2). Significant differences in ICP with increasing
ETCO2 were seen across 40, 50, and 70 mm Hg (P < .05 for all). The
magnitude of effect on ICP was decreased at higher ETCO2 (Figure 4,
Table 2).
3.3 | ICP recording in conscious dogs
Post-anesthesia ICP results were found to be significantly different
based on both body and head position across time (P < .001;
Figure 5). Pairwise comparisons showed significant differences in ICP
among standing/head elevated, standing/head down, sternal/head
elevated, and sternal/head down (P < .05 for all; Table 3). Mean
values for ICP increased by >100% comparing head elevation to head
down positions (Figure 5). Other activities that were noted to
TABLE 1 Mean physiological variables (SD) of all dogs at baseline and maximal physiological manipulations
Time point ICP (mm Hg) (n = 6) MAP (mm Hg (n = 6) CPP (mm Hg) (n = 6) PaCO2 (mm Hg) (n = 6)
Baseline 1 7.2  3.8 86.1  8.5 78.9  7.6 39.8  3.4
JUG 90 30.8  10.4 101.0  13.4 70.2  13.4 39.4  2.2
CO2 70 20.1  7.5 93.9  23.4 73.8  19.2 70.61  5.0
Baseline 2 9.5  3.3 113.8  14.6 104.3  13.9 40.1  1.7
Abbreviations: IC, intracranial pressure; CPP, cerebral perfusion pressure; MAP, mean arterial pressure; PaCO2, arterial carbon dioxide partial pressure.
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consistently result in transient marked increases in ICP included
stretching, head shaking, and large excursions of the head from side
to side.
3.4 | Pathology
Grossly, after removal of the dura, the entire surface of the brain
appeared normal in 4/7 dogs except for 1-mm holes in the right ros-
tral and caudal locations where transducer cables had entered the
brain as a consequence of intraparenchymal transducer placement.
One of these dogs had a 0.5 cm × 0.8 cm mass arising from the dura
0.5 cm rostral to the left rostral catheter. Histological examination
confirmed the mass to be a meningioma. In 3/7 dogs, gross abnormali-
ties were noted on the surface of the brain; in 2/3 of these dogs,
3-4 mm focal hemorrhages were present at the point where some of
the catheters penetrated the dura. A small amount of blood was evi-
dent in the tracks of IP transducers on the right cerebrum in both
dogs. In the 3rd dog, a subdural hemorrhage was present, extending
over much of the surface of the right cerebrum, including the location
of the right caudal transducer. The hemorrhage had remained superfi-
cial and was not causing compression, swelling or edema of the cere-
bral hemisphere (Figure 6). Histological examination of the brain
surrounding the area of microsensor placement showed a clearly
demonstrable tract from IP transducer placement that in some
instances had small areas of hemorrhage, especially where the tip of
the sensor was located (Figure 6). No polymorphonuclear, lympho-
cytic, or macrophage infiltration was present in any of the dogs.
4 | DISCUSSION
The Codman MicroSensor has been shown to provide reliable and
accurate ICP measurements in human patients compared to a variety
of ICP monitoring techniques.33–37 The results of our study support
the use of the Codman MicroSensor in dogs as a simple method for
FIGURE 2 Mean ICP (SD) for all dogs (black lines) recorded from all
transducer locations after progressive restriction of cranial venous
outflow secondary to jugular occlusion. ICP readings were similar for
all transducer sites whether from rostral, caudal, intraparenchymal, or
subdural locations. Recordings from Dog 4 (red lines) were excluded
from analysis because of outlying data, subsequently attributed to the
presence of an intracranial mass lesion (meningioma) found at
necropsy. B1 and B2 are baseline time points before and after
manipulation, respectively
FIGURE 3 Boxplots of ICP at various jugular occlusion pressures. ICP
values increase with increasing occlusion pressure. Whiskers
represent 1.5 interquartile ranges
TABLE 2 Mean ICP results (SD) in all dogs after physiological
maneuvers of jugular occlusion (JUG) and increase in ETCO2
Time point ICP (mm Hg) P value
JUG (mm Hg) <.001
0 7.2  3.8a
20 13.9  7.2b
40 19.0  6.6c
50 23.3  6.6c,d
60 25.3  7.2d,e
70 27.9  7.9d,e,f
80 29.2  8.5e,f
90 30.8  10.4f
0 6.4  4.1a
ETCO2 (%) <.001
0 6.4  4.1g
40 10.0  5.1g
50 15.2  7.6h
60 19.3  8.1h,i
65 17.2  5.6h,i
70 20.1  7.5i
0 9.3  3.3g
Likelihood ratio test P value from the linear mixed models showed overall
significant effects of both manipulations.
a ICP means that have no superscript in common were significantly differ-
ent from each other (Tukey's honest significance difference
test, P < .05).
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obtaining continuous direct ICP measurements in anesthetized and
awake animals in the clinical setting. Lack of cumbersome anchoring
equipment and the ability to interface with a wide variety of patient
monitoring systems were clinically relevant advantages. Removal of
the transducer is relatively simple compared to bolt-based systems
and can be done without surgery in the conscious dog. Moreover, the
absence of significant differences in ICP readings based on rostral/
caudal positioning or intraparenchymal versus subdural placement has
implications for clinical use, because flexibility in the placement of the
rostrotentorial burr hole may be advantageous in the clinical setting.
Although clinically apparent neurological deficits were not documen-
ted, pathology associated with intraparenchymal placement was pre-
dictably more apparent (Figure 6), supporting the use of subdural
placement. Additionally, the Codman MicroSensor has been shown to
be safe, have acceptable function, and produce minimal imaging arti-
fact during MRI as long as manufacturer's imaging guidelines are
strictly followed.38–40
Choice of monitoring locations for our study was made consider-
ing assessment of potential clinical sequelae, including ease of place-
ment, minimization of adverse effects, and reliability of readings.
Noninvasive methods for ICP measurement would have been ideal,
but these have not been shown to be sufficiently reliable for routine
clinical use.41,42 Intraparenchymal transducers are the mainstay for
monitoring ICP in humans5,43,44 and provided consistent readings in
our study. Subdural transducer placement provided a less invasive
option, but less data exist regarding the relative value and accuracy of
subdural ICP monitoring devices, and subdural readings may be less
accurate than intraparenchymal readings. However, our study found
no difference between subdural and intraparenchymal transducer
readings, consistent with a previous study in dogs using a bolt-based
solid-state transducer45 and subdural ICP device studies across sev-
eral species.25,36,37,45–51
The effects of head and body position in our study were notable
in their magnitude and are relevant to ICP management in the clinical
setting. An increase in ICP associated with head down positioning was
seen in all dogs as predicted by ICH physiology, although head posi-
tion was reported to have no effect on ICP in anesthetized dogs in a
previous study.17 The increase in mean ICP (approximately +7.6 mm
Hg/+100%) with head down positioning in sternally recumbent con-
scious dogs in our study is more consistent with a previous report of
similar maneuvers in conscious dogs in lateral recumbency.10
The maximal recorded increase in mean ICP (approximately +16.5 mm
Hg/+180%) occurred after head down positioning in standing dogs
(Figure 5, Table 3) and likely reflects the higher potential for attaining
a head position below the level of the heart compared to sternally
positioned dogs. Optimal head elevation has been well documented
to result in decreased ICP in human traumatic brain injury patients,52
although effect on clinical outcome is less defined.53 Large ICP varia-
tions with head position in our study in normal dogs similarly highlight
FIGURE 5 Mean ICP (SD) associated with head and body position
in conscious dogs measured every 2 hours post-anesthesia. Head
down postures consistently resulted in increase of mean ICP values
by 100%
TABLE 3 Mean ICP results (SD) in all dogs with altered body and
head positions
Position ICP (mm Hg) P value
<.001
Standing/up 9.2  5.2a
Standing/down 25.7  6.7b
Sternal/up 7.6  8.1c
Sternal/down 15.2  8.1d
Likelihood ratio test P value from the linear mixed model showed overall
significant effects of changes in head and body position, adjusted for time
elapsed after anesthesia.
a ICP means that have no superscript in common were significantly different
from each other (Tukey's honest significance difference test, P < .05).
FIGURE 4 Boxplots of ICP at various end-tidal partial pressure of
carbon dioxide (ETCO2) manipulations. ICP values increase with
increasing CO2. Whiskers represent 1.5 interquartile ranges
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the likely importance of this basic nursing component on ICP manage-
ment in dogs with ICH.
No clinically apparent adverse events were seen in the study
dogs, although minor pathological sequelae were seen at necropsy.
Adverse events associated with choice of monitoring device and loca-
tion have been well documented in human patients for intraventricu-
lar devices with external ventricular drainage compared to
intraparenchymal solid state sensors. Hemorrhage associated with
intraventricular devices occurs in approximately 10% of cases
although <1% is clinically relevant,54 and infection rates have been
reported in up to 20% of cases.55 Reported complications for intrapar-
enchymal devices are markedly lower56,57 and are <0.5% in reported
studies in humans for the Codman MicroSensor, similar to what was
observed in our study.34 Fewer data are available for subdurally
placed sensors, however complications in our study and in humans
with a subdural Codman MicroSensor also were uncommon.37
Limitations of our study include lack of measurement of ICP using
an intraventricular “gold standard,” no assessment of device “drift”
(loss of accuracy of device readings because of change in scale zero
over time), and assessment of ICP in normal dogs in the absence of
defined structural brain lesions. However, physiological maneuvers
known to increase ICP produced consistent and predictable responses
in the anesthetized dogs (Figures 2–4), and baseline ICP results
(approximately 7-12 mm Hg) consistent with the current findings in
anesthetized normal dogs have been reported previously using gold
standard direct ventricular CSF measurements,6 and other intracranial
locations (intraparenchymal, subarachnoid,9,12,17,21 and at the cisterna
magna7,8). Non-anesthetized dogs in sternal recumbency in our study
also had mean ICP results in a range (7-15 mm Hg) consistent with
previous reports in conscious dogs, suggesting a minimal effect of the
anesthesia protocol in these animals.9,10
Drift in micro-strain-gauge devices, and specifically in the Cod-
man MicroSensor, has been shown to be small in laboratory studies
and in clinical studies in humans, even over several days,34–36 and any
effects on device location comparisons over 24 hours in our study
were likely to be small. No differences were seen in ICP results in our
study related to transducer placement within the cranial vault, but it is
not possible to extrapolate these findings in normal dogs to a
pathological setting. Craniospinal and suprainfratentorial pressure gra-
dients with intracranial lesions generally are accepted to exist, but
debate still exists in human medicine regarding the presence of inter-
hemispheric gradients, particularly with focal lesions.58–60 After exper-
imental epidural lesions in dogs,45 no differences were seen in ICP
using ipsilateral or contralateral measurements recorded from ventric-
ular, intraparenchymal, or subdural transducer locations. Anecdotally,
increased ICP results in the 1 dog (Figure 5) with an intracranial
meningioma also were found to be similar for all catheter locations.
Current recommendations in human medicine are to place devices
ipsilateral to mass lesions when clinically appropriate.61 Further study
in dogs will be required to define optimal placement relative to spe-
cific lesions.
Based on the pathological findings in these dogs, the Codman
MicroSensor ICP devices stayed secure throughout the course of the
study and appeared to be tolerated well by the animals. Focal hemor-
rhages around the dural insertion site were seen in 2 of the dogs with
more widespread hemorrhage over the majority of the cerebral hemi-
sphere in an additional dog. All hemorrhage appeared to be self-
limiting with no apparent effect on ICP or clinical signs, but compro-
mise of dural vessels is a potential issue that may require a larger burr
hole diameter to better visualize meningeal vasculature. Pathology
after intraparenchymal placement was similar to that of previous
reports after placement of other ICP devices in dogs in this loca-
tion.10,17 The lack of apparent clinical signs resulting from CNS pathol-
ogy in these reports and the current study, together with extensive
clinical data in humans, support the use of intraparenchymal place-
ment of ICP sensors. Obvious histopathological sequelae are however
present after intraparenchymal placement, and the lack of difference
in ICP measurement between intraparenchymal and subdural loca-
tions for the Codman MicroSensor supports the placement in a sub-
dural location.
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transducer (arrow) is likely the source of this hemorrhage. (B) Hematoxylin and eosin histological transverse section of brain showing hemorrhage
within the neuropil associated with intraparenchymal transducer placement. Bar size: A = 1 cm, B = 500 μm
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